Examkin

Question

Difficulty: MediumMonitoring and Treatment Evaluation

A 57-year-old woman comes to the clinic reporting severe, generalized muscle aches and profound fatigue that began two days ago. She also notes that her urine has become unusually dark, resembling the color of tea. Five days ago, she was diagnosed with Helicobacter pylori infection and was started on a 14-day eradication regimen consisting of pantoprazole, amoxicillin, and clarithromycin. Her past medical history is significant for hyperlipidemia and hypertension, for which she takes simvastatin and lisinopril daily. Her temperature is 37.1°C (98.8°F), blood pressure is 126/82 mmHg, and pulse is 78/min. Physical examination reveals tenderness to palpation over the bilateral deltoid and quadriceps muscles. Neurologic examination shows 4/5 strength in the proximal upper and lower extremities with normal deep tendon reflexes. A urine dipstick performed in the clinic is positive for 3+ blood, but the microscopic examination reveals 0 to 1 red blood cells per high-power field. Which of the following is the most appropriate next step in the management of this patient?

  1. Discontinue simvastatin and obtain a serum creatine kinase levelAnswer
  2. B
    Discontinue simvastatin, initiate atorvastatin, and obtain a serum creatine kinase level
  3. C
    Initiate empiric ciprofloxacin for a suspected urinary tract infection
  4. D
    Obtain a comprehensive metabolic panel to check liver enzymes and continue the current medication regimen
  5. E
    Schedule an urgent electromyography to evaluate for toxic myopathy

Answer

The most appropriate next step is to discontinue simvastatin and obtain a serum creatine kinase level.
The correct action is to discontinue simvastatin and obtain a serum creatine kinase level. The patient has developed statin-induced rhabdomyolysis triggered by the recent addition of clarithromycin. Simvastatin undergoes extensive first-pass metabolism by the hepatic enzyme CYP3A4. Clarithromycin is a potent CYP3A4 inhibitor. When given together, simvastatin levels rapidly rise to toxic concentrations, causing skeletal muscle breakdown. This breakdown releases myoglobin into the bloodstream, which is filtered by the kidneys and causes the urine to appear dark. Myoglobin triggers a positive "blood" reading on a urine dipstick, but true red blood cells will be absent on microscopic examination. The immediate management involves stopping the offending statin to halt further muscle damage and measuring a serum creatine kinase (CK) level to confirm rhabdomyolysis and guide intravenous hydration therapy.

Step-by-Step Solution

1
Interpret the clinical and laboratory presentation.
The patient exhibits proximal muscle weakness, myalgias, and tea-colored urine, with a urinalysis showing false-positive blood (positive dipstick, negative microscopy).
This combination is the classic presentation of rhabdomyolysis with myoglobinuria, where myoglobin cross-reacts with the dipstick reagent for hemoglobin.
2
Identify the underlying etiology by reviewing the medication list.
The patient recently started clarithromycin while taking maintenance simvastatin.
Clarithromycin is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) isoenzyme, which is responsible for metabolizing simvastatin. This leads to toxic systemic accumulation of the statin.
3
Determine the most appropriate immediate management.
Stop the simvastatin and order a serum creatine kinase (CK) level.
Removing the precipitating medication prevents further muscle necrosis, and a CK level is required to confirm the diagnosis and guide the need for aggressive intravenous fluid resuscitation to protect renal function.

Key Concept

The concomitant use of strong CYP3A4 inhibitors (e.g., macrolides like clarithromycin) and CYP3A4-metabolized statins (e.g., simvastatin, lovastatin, atorvastatin) can precipitate life-threatening rhabdomyolysis, requiring immediate discontinuation of the statin and assessment of serum creatine kinase.
Rate this question

Topics

Monitoring and Treatment Evaluation

More questions from this topic